KMTS vs TER · rev $95.1M vs P/E 76, rev $2.61B
Kestra Medical Technologies, Ltd. Common Stock (KMTS) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported KMTS revenue for 2026-04-30 was $95.1M. Net income was -$131.6M. Revenue was up 59.0% from 2025-04-30 to 2026-04-30. KMTS currently screens at market cap $1.24B.
Latest reported TER revenue for 2026-06-28 was $2.61B. Net income was $773.4M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
KMTS currently screens at market cap $1.24B. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the KMTS and TER stock pages for the full models.
Not investment advice.